172 results on '"Bulkow, Lisa R."'
Search Results
2. Hepatocellular Carcinoma Risk in Alaska Native Children and Young Adults with Hepatitis B Virus: Retrospective Cohort Analysis
3. Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children
4. Long-Term Immunogenicity of Hepatitis A Virus Vaccine in Alaska 17 Years After Initial Childhood Series
5. Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Alaska Native Adults 55-70 Years of Age
6. Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55–74 years living in Alaska: No evidence of hyporesponsiveness
7. Hepatitis B Virus Genotypes in Alaska Native People with Hepatocellular Carcinoma: Preponderance of Genotype F
8. Persistence of Seropositivity Among Persons Vaccinated for Hepatitis A During Infancy by Maternal Antibody Status: 15-Year Follow-up
9. Impact of a statewide childhood vaccine program in controlling hepatitis A virus infections in Alaska
10. Serotype Distribution and Antimicrobial Resistance Patterns of Invasive Isolates of Streptococcus pneumoniae: Alaska, 1991-1998
11. Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization Program
12. Protection Provided by Hepatitis B Vaccine in a Yupik Eskimo Population: Results of a 10-Year Study
13. Clearance of Hepatitis B e Antigen in Patients With Chronic Hepatitis B and Genotypes A, B, C, D, and F
14. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage
15. Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults
16. Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska
17. Relationship between IgE and specific aeroallergen sensitivity in Alaskan native children
18. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up
19. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program
20. Viral Respiratory Infections in Hospitalized and Community Control Children in Alaska
21. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity
22. Hepatitis B-associated vasculitis in Alaska Natives: viral genotype, clinical and serologic outcome
23. Immunogenicity and Reactogenicity to Haemophilus Influenzae Type b (Hib) Conjugate Vaccine among Rural Alaska Adults
24. Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up
25. Estimating the Date of Hepatitis C Virus Infection from Patient Interviews and Antibody Tests on Stored Sera
26. Dietary change and obesity associated with glucose intolerance in Alaska natives
27. Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults
28. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: The impact of persistent oropharyngeal carriage
29. Invasive Haemophilus influenzae Disease in Alaskan Residents Aged 10 Years and Older Before and After Infant Vaccination Programs
30. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers
31. Transplacental Respiratory Syncytial Virus and Influenza Virus Antibody Transfer in Alaska Native and Seattle Mother–Infant Pairs.
32. Epidemiology of Invasive Pneumococcal Disease [with Reply]
33. Secular Trends in Hepatitis A Virus Infection among Alaska Natives
34. The Prevalence of Cervical Infection with Human Papillomaviruses and Cervical Dysplasia in Alaska Native Women
35. The Epidemiology of Invasive Pneumococcal Disease in Alaska, 1986-1990: Ethnic Differences and Opportunities for Prevention
36. Serotype Distribution and Antimicrobial Resistance Patterns of Invasive Isolates of Streptococcus pneumoniae: Alaska 1986-1990
37. Prevalence of Helicobacter pylori among Alaskans: Factors associated with infection and comparison of urea breath test and anti‐Helicobacter pylori IgG antibodies.
38. Declines in traditional marine food intake and vitamin D levels from the 1960s to present in young Alaska Native women.
39. Population structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013.
40. Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.
41. A survey of knowledge, attitudes, and practices towards skin and soft tissue infections in rural Alaska.
42. Eighteen Years of Respiratory Syncytial Virus Surveillance.
43. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: A retrospective case-control study.
44. The 13-Valent Pneumococcal Conjugate Vaccine for Invasive Pneumococcal Disease in Alaska Native Children.
45. Migration of persons between households in rural Alaska: considerations for study design.
46. Diabetes prevalence, incidence, complications and mortality among Alaska Native people 1985-2006.
47. ▪Clearance of Hepatitis B e Antigen in Patients With Chronic Hepatitis B and Genotypes A, B, C, D, and F.
48. Respiratory Syncytial Virus Season and Hospitalizations in the Alaskan Yukon-Kuskokwim Delta.
49. Decline in Respiratory Syncytial Virus Hospitalizations in a Region With High Hospitalization Rates and Prolonged Season.
50. Risk Factors for Severe Respiratory Syncytial Virus Infection Among Alaska Native Children.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.